medroxyprogesterone and Precancerous Conditions
medroxyprogesterone has been researched along with Precancerous Conditions in 9 studies
Research
Studies (9)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (77.78) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Kaino, T; Sager, G; Vereide, AB; Ørbo, A | 1 |
Castaneda, TA; Gambrell, RD; Massey, FM; Ricci, CA; Ugenas, AJ; Wright, JM | 1 |
Kedzia, H; Warenik-Szymankiewicz, A; Wolna, M | 1 |
Bonte, J | 1 |
Miura, K; Nagasawa, H; Nakajima, K; Namiki, H; Niki, K; Noguchi, Y; Ohta, K | 1 |
Aoki, M; Ishida, M; Nagasawa, H; Sakagami, N | 1 |
Dallenbach-Hellweg, G | 1 |
Fujii, M; Hagiwara, K; Nagasawa, H | 1 |
Izutsu, T; Kagabu, T; Kurokawa, Y; Nishiya, I; Satoh, K; Yoshizumi, N | 1 |
Reviews
1 review(s) available for medroxyprogesterone and Precancerous Conditions
Article | Year |
---|---|
[Conservative organ-preserving measures in precancerous stages of endometrial cancer].
Topics: Adult; Endometrial Hyperplasia; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Precancerous Conditions; Uterine Neoplasms | 1988 |
Trials
1 trial(s) available for medroxyprogesterone and Precancerous Conditions
Article | Year |
---|---|
Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
Topics: Administration, Oral; Adult; Aged; Apoptosis; bcl-2-Associated X Protein; Biopsy; Dose-Response Relationship, Drug; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Middle Aged; Precancerous Conditions; Progestins; Proto-Oncogene Proteins c-bcl-2 | 2005 |
Other Studies
7 other study(ies) available for medroxyprogesterone and Precancerous Conditions
Article | Year |
---|---|
Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Progesterone; Prospective Studies; Risk; Uterine Neoplasms | 1980 |
[Conservative treatment of two young women with cancer and precancerous lesions of the endometrium].
Topics: Adult; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone; Precancerous Conditions; Treatment Outcome | 1994 |
[Beneficial effects of contraceptive doses and large doses of medroxyprogesterone in the prevention and treatment of uterine hyperplasia].
Topics: Adenocarcinoma; Adult; Contraceptive Agents, Female; Endometriosis; Female; Humans; Medroxyprogesterone; Middle Aged; Precancerous Conditions; Uterine Cervical Neoplasms; Uterine Neoplasms | 1978 |
Interrelationship between pituitary and ovarian hormones in normal and neoplastic growth of mammary glands of mice.
Topics: Animals; Cell Transformation, Neoplastic; DNA; DNA Replication; Estrogens; Female; Growth Hormone; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Ovary; Precancerous Conditions; Progesterone; Prolactin | 1986 |
Medroxyprogesterone acetate enhances spontaneous mammary tumorigenesis and uterine adenomyosis in mice.
Topics: Animals; Cell Transformation, Neoplastic; Endometriosis; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Organ Size; Precancerous Conditions; Uterine Neoplasms | 1988 |
Inhibition by medroxyprogesterone acetate of precancerous mammary hyperplastic alveolar nodule formation in mice.
Topics: Animals; Antineoplastic Agents; Body Weight; Estrus; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred Strains; Organ Size; Precancerous Conditions; Pregnancy; Prolactin | 1985 |
[Flow cytometric study on the action of progestogen in patients with adenocarcinoma and precancerous lesions of the endometrium].
Topics: Adenocarcinoma; Adult; Aged; Cell Cycle; DNA, Neoplasm; Female; Flow Cytometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Precancerous Conditions; RNA, Neoplasm; Software; Uterine Neoplasms | 1985 |